is retatrutide a glp-3 (RT) | Advanced Weight Loss Support GLP-3 10mg | Research Use

Ferrulli and colleagues ran a randomized, sham-controlled trial of 33 adults with obesity: deep TMS targeting the PFC and insula for five weeks produced significant weight loss that persisted at 12-month follow-up [16]

GLP1-RAs are commonly used as a weight loss drug and side effects may include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation and abdominal pain

Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: A systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials

Share: A major study from Cleveland Clinic found that people with both obesity and type 2 diabetes who had weight-loss surgery lived longer and experienced fewer serious health issues than those who used GLP-1 receptor agonist medications alone

ELIXA trial included patients with recent cardiovascular event (patients with acute coronary syndrome 180 days before randomization), and although there was no benefit in MACE reduction in lixisenatide treated patients compared to placebo, results revealed cardiovascular safety of lixisenatide in this specific high risk population (38, 40)

Hormonal shifts during perimenopause and menopauseparticularly the drop in estrogen, progesterone, and DHEAcreate a cascade of changes in the body: Slower metabolism (especially after age 40) Increased insulin resistance Visceral fat accumulation (around the belly and midsection) Disrupted sleep and cortisol imbalance Loss of lean muscle mass This isnt just about appearance